# Fortress Biotech, Inc. (FBIOP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FBIOP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 34.76M | $ 109.91M | $ 144.50M | $ 64.78M | $ 164.14M |
| 2025 | $ 64.77M | $ 6.98M | $ -67.35M | $ 74.30M | $ 49.87M |
| 2024 | $ 60.62M | $ -48.35M | $ -84.29M | $ 75.96M | $ 22.74M |
| 2023 | $ 91.38M | $ -65.56M | $ -139.83M | $ 84.66M | $ 22.54M |
| 2022 | $ 84.61M | $ -96.71M | $ -248.55M | $ 127.34M | $ 41.72M |
| 2021 | $ 81.77M | $ -76.91M | $ -157.96M | $ 74.98M | $ 108.67M |
| 2020 | $ 58.09M | $ -59.27M | $ -115.73M | $ 89.08M | $ 100.34M |
| 2019 | $ 47.28M | $ -51.58M | $ -134.70M | $ 115.14M | $ 26.22M |
| 2018 | $ 35.50M | $ -111.13M | $ -142.90M | $ 79.50M | $ 1.85M |
| 2017 | $ 252.70M | $ -90.09M | $ -122.42M | $ 66.51M | $ 52.57M |
| 2016 | $ 22.67M | $ -75.80M | $ -77.48M | $ 28.22M | $ 38.50M |
| 2015 | $ 1.21M | $ -68.00M | $ -45.43M | $ 23.41M | $ 56.85M |
| 2014 | $ 0 | $ -28.81M | $ -23.08M | $ 14.44M | $ 70.52M |
| 2013 | $ 0 | $ -52.85M | $ -42.43M | $ 13.62M | $ 81.28M |
| 2012 | $ 0 | $ -39.86M | $ -33.89M | $ 12.39M | $ 22.03M |
| 2011 | $ 0 | $ -53.42M | $ -16.09M | $ 750.0K | $ 19.13M |
| 2010 | $ 0 | $ -5.68M | $ -1.31M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.39 |
| Liabilities / Eq | 0.67 |
| Current Ratio | 3.96 |

## Other views

- [Metrics](https://sponda.capital/en/FBIOP.md)
- [Charts](https://sponda.capital/en/FBIOP/charts.md)
- [Compare](https://sponda.capital/en/FBIOP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.